Physician profile
Muhammad Hefzy
NPI 1346496304
$1,494.34
in general payments reported to CMS, 2019-2025
14 companies · $55.01 in 2025
The $55.01 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $332 · 2021: $254 · 2022: $147 · 2024: $109 · 2025: $55.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $163.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $544.52 | 2019-2024 | Ionicrf |
| Boston Scientific Corporation | $404.46 | 2019-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, General - Pain Management |
| Nevro Corp. | $161.76 | 2019-2022 | |
| Allergan, INC. | $69.94 | 2019-2021 | |
| Medtronic, INC. | $68.88 | 2021-2024 | Intellis Adaptivestim |
| Medtronic USA, INC. | $52.35 | 2019 | |
| Pfizer INC. | $41.24 | 2019-2020 | |
| Amgen INC. | $39.13 | 2019 | |
| Scilex Pharmaceuticals INC. | $27.61 | 2019 | |
| Abbvie INC. | $21.00 | 2024 | |
| Arbor Pharmaceuticals, INC. | $18.96 | 2021 | |
| Biodelivery Sciences International, INC. | $15.88 | 2021 | |
| Medline Industries LP | $14.71 | 2021 | |
| Lilly USA, LLC | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Hefzy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.